Korean J Hematol 1994; 29(3):
Published online September 30, 1994
© The Korean Society of Hematology
급성백혈병과 고형종양 환자에서 피하 중심정맥포트의 비교
이순남, 김광호
이화여자대학교 의과대학 내과학교실,
이화여자대학교 의과대학 흉부외과학교실
Use and Complications of Subcutaneously Impfantable Port in Patients with Acute Leukemia and Solid Tumors
Background:Reliable venous access is increasing serious problem in cancer chemotherapy patients especially in patients with leukemia. We evaluated the difference of
complications of subcutaneously implanted port in patients with acute leukemia comparing to the complications in patients with solid tumors.
Methods:Forty eight implantable second generation ports were placed subcutaneously in 17 acute leukemic patients and 30 patients with various soild tumors. The function
time and complications of port were studied.
Results:In acute leukemia patients, ports were in placed for an average of 189 days(range 15-642+6ays) and 221 days(range 10-1,395+4days) in patients with solid tumor(p>0.05).
Complications included infections in 2 cases(11.7%) in acute leukemia and 1 case(3.2%) in solid tumor group, thrombosis in 1 case(3.2%) in only solid tumor group, skin
laceration in 1 case respectivly(5.9%, 3.2%) and pneumothorax in 1 case(3.2%) in solid tumor group(p>0.05). Six ports were removed due to complication except pneumothorax managed conservatively. And blood samplings were all accessible.
Conclusion: The overall rate of catheter associated complications in patients with acute leukemia was not higher than in patients with solid tumors. Since port can be used safely in patients with acute leukemia as well as in patients with solid tumor for long term intravenous chemotherapy.
Keywords Acute leukemia; Subcutaneous Implantable Port; Solid tumor;
PDF
Standard view
Export citation
Share Article
Korean J Hematol 1994; 29(3): 317-323
Published online September 30, 1994
Copyright © The Korean Society of Hematology.
급성백혈병과 고형종양 환자에서 피하 중심정맥포트의 비교
이순남, 김광호
이화여자대학교 의과대학 내과학교실,
이화여자대학교 의과대학 흉부외과학교실
Use and Complications of Subcutaneously Impfantable Port in Patients with Acute Leukemia and Solid Tumors
Soon Nam Lee, Kwang Ho Kim
Department of Internal Medicine, Thoracic Cardiovascular Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
Abstract
Background:Reliable venous access is increasing serious problem in cancer chemotherapy patients especially in patients with leukemia. We evaluated the difference of
complications of subcutaneously implanted port in patients with acute leukemia comparing to the complications in patients with solid tumors.
Methods:Forty eight implantable second generation ports were placed subcutaneously in 17 acute leukemic patients and 30 patients with various soild tumors. The function
time and complications of port were studied.
Results:In acute leukemia patients, ports were in placed for an average of 189 days(range 15-642+6ays) and 221 days(range 10-1,395+4days) in patients with solid tumor(p>0.05).
Complications included infections in 2 cases(11.7%) in acute leukemia and 1 case(3.2%) in solid tumor group, thrombosis in 1 case(3.2%) in only solid tumor group, skin
laceration in 1 case respectivly(5.9%, 3.2%) and pneumothorax in 1 case(3.2%) in solid tumor group(p>0.05). Six ports were removed due to complication except pneumothorax managed conservatively. And blood samplings were all accessible.
Conclusion: The overall rate of catheter associated complications in patients with acute leukemia was not higher than in patients with solid tumors. Since port can be used safely in patients with acute leukemia as well as in patients with solid tumor for long term intravenous chemotherapy.
Keywords: Acute leukemia, Subcutaneous Implantable Port, Solid tumor,
Previous Article
